Marketing - Press Releases

Date	Title	Company
26-Nov-2019	Vaccitech provides update on clinical progress for its two Phase 2 Universal Influenza studies	Vaccitech Ltd
26-Nov-2019	SK Life Science, Inc. Receives US FDA Approval for cenobamate tablets for the Treatment of Partial-Onset Seizures in Adults with Epilepsy	Arvelle Therapeutics
26-Nov-2019	ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer	ERYTECH
26-Nov-2019	Data on Tepotinib for metastatic non–small cell lung cancer presented at ESMO Asia 2019	Merck
26-Nov-2019	Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death	Novartis
26-Nov-2019	Mental health must be priority for next government, says Mental Health Network	The NHS Confederation Mental Health Network (MHN)
26-Nov-2019	Conservative manifesto makes welcome promises on staffing but falls short on social care, says NHS Confederation	The NHS Confederation
26-Nov-2019	ABPI response to funding pledges on dementia research and innovative medicines	ABPI
26-Nov-2019	Bempedoic Acid Lowers LDL-Cholesterol without Adversely Impacting Glycaemic Control in Pooled Analyses of Phase 3 Trials Presented at the American Heart Association 2019 Scientific Sessions	Daiichi Sankyo Europe GmbH
26-Nov-2019	HEALTHY.IO ANNOUNCES ROLL OUT OF DIP UTI SMARTPHONE URINALYSIS KIT AT DAY LEWIS PHARMACIES	Healthy.io
26-Nov-2019	Marinomed – Clinical Data Show Rapid Onset of Action of Budesolv to Alleviate Hay Fever	Marinomed Biotech AG
21-Nov-2019	Top decision makers to present at SMi’s 9th Annual Pharmaceutical Microbiology Conference 2020	SMi Group
18-Nov-2019	Castor Establishes Advisory Board of Industry Leaders to Maximize the Impact of its Clinical Data Platform	Castor
18-Nov-2019	Bayer’s new hands-on ‘Heart Mechanics’ workshop aims to inspire the cardio engineers of the future: the latest learning resource available free for schools at the Baylab science laboratory	Baylab
18-Nov-2019	Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea	Jazz Pharmaceuticals
18-Nov-2019	Bimekizumab Positive Results Confirmed in Second Phase 3 Psoriasis Study	UCB
18-Nov-2019	Novartis receives positive CHMP opinion for Mayzent® (siponimod), the first and only oral treatment for secondary progressive multiple sclerosis with active disease	Novartis
18-Nov-2019	Securecell Introduces Sephara, a Novel, Silicon-Based In-Situ Filtration Membrane	Securecell
18-Nov-2019	Consistent effects of FARXIGA in heart failure patients with reduced ejection fraction shown in new analyses from landmark Phase III DAPA-HF trial	AstraZeneca
18-Nov-2019	Time for an evidence review of OTC analgesics?	Havas SO